Short-term assessment of non-surgical periodontal therapy reduces oral pathogens and pro-inflammatory cytokines, enhancing clinical outcomes in patients with chronic kidney disease

BACKGROUND: Periodontal diseases have been reported to be associated with chronic kidney disease (CKD) progression. Thus, this study aimed to evaluate non-surgical periodontal therapy (NSPT) in patients with CKD disease progression by monitoring oral parameters, pathogen levels, cytokine profiles, and kidney function. METHODS: Forty-five participants (age 60.0 ± 8.5 years) were examined at baseline and at 3 months after NSPT for oral parameters, oral pathogens (Porphyromonas gingivalis, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, Candida albicans), cytokines (IL-6, IL-8, TNF-α, IL-10), and kidney functions (serum creatinine, eGFR, urine protein-creatinine ratio). RESULTS: At baseline, the CKD patients were diagnosed with stage II-IV periodontitis and exhibited measurable periodontal pathogen levels (P. gingivalis, 1.2 log CFU/mL; F. nucleatum, 4.4 log CFU/mL; A. actinomycetemcomitans, 0.3 log CFU/mL; and C. albicans, 4.1 log CFU/mL). Concurrently, pro-inflammatory cytokine concentrations were recorded at 0.2-4.4 pg/mL for IL-6, 1.9-25.5 pg/mL for IL-8, and 0.0-26.1 pg/mL for TNF-α. Conversely, IL-10 levels ranged from 0.0 to 13.2 pg/mL. After 3 months of NSPT, the levels of pathogens (1.1-10.9 fold) and cytokines (1.2-2.6 fold) were significantly reduced, while IL-10 levels significantly increased (0.7-1.9 fold). The number of patients showing improvement for serum creatinine and urine protein-creatinine ratio in CKD patients was 59.1-71.4% and 60.9-90.0%, respectively. CONCLUSION: Our findings suggest that NSPT may benefit CKD patients by reducing oral pathogens and inflammation while increasing IL-10. There was evidence of a possible trend towards enhanced kidney function in CKD patients treated with NSPT. TRIAL REGISTRATION: The study was registered in the Thai Clinical Trials Registry (TCTR20240516002; registered date 16 May 2024), Thailand.

Authors

Institutions

Publication Details

Journal
BMC Oral Health
Published
2026-06-17
DOI
https://doi.org/10.1186/s12903-026-08906-2
Primary Topic
Oral microbiology and periodontitis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-term assessment of non-surgical periodontal therapy reduces oral pathogens and pro-inflammatory cytokines, enhancing clinical outcomes in patients with chronic kidney disease

Supontep Teerakanok, Rawee Teanpaisan, Praphansri Ruangsri, Nuntiya Pahumunto et al.
BMC Oral Health
Oral microbiology and periodontitis research
article

Short-term assessment of non-surgical periodontal therapy reduces oral pathogens and pro-inflammatory cytokines, enhancing clinical outcomes in patients with chronic kidney disease

Supontep Teerakanok, Rawee Teanpaisan, Praphansri Ruangsri, Nuntiya Pahumunto, Mutita Wongsuwanlert, Pornpen Sangthawan
article en

Abstract

BACKGROUND: Periodontal diseases have been reported to be associated with chronic kidney disease (CKD) progression. Thus, this study aimed to evaluate non-surgical periodontal therapy (NSPT) in patients with CKD disease progression by monitoring oral parameters, pathogen levels, cytokine profiles, and kidney function. METHODS: Forty-five participants (age 60.0 ± 8.5 years) were examined at baseline and at 3 months after NSPT for oral parameters, oral pathogens (Porphyromonas gingivalis, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, Candida albicans), cytokines (IL-6, IL-8, TNF-α, IL-10), and kidney functions (serum creatinine, eGFR, urine protein-creatinine ratio). RESULTS: At baseline, the CKD patients were diagnosed with stage II-IV periodontitis and exhibited measurable periodontal pathogen levels (P. gingivalis, 1.2 log CFU/mL; F. nucleatum, 4.4 log CFU/mL; A. actinomycetemcomitans, 0.3 log CFU/mL; and C. albicans, 4.1 log CFU/mL). Concurrently, pro-inflammatory cytokine concentrations were recorded at 0.2-4.4 pg/mL for IL-6, 1.9-25.5 pg/mL for IL-8, and 0.0-26.1 pg/mL for TNF-α. Conversely, IL-10 levels ranged from 0.0 to 13.2 pg/mL. After 3 months of NSPT, the levels of pathogens (1.1-10.9 fold) and cytokines (1.2-2.6 fold) were significantly reduced, while IL-10 levels significantly increased (0.7-1.9 fold). The number of patients showing improvement for serum creatinine and urine protein-creatinine ratio in CKD patients was 59.1-71.4% and 60.9-90.0%, respectively. CONCLUSION: Our findings suggest that NSPT may benefit CKD patients by reducing oral pathogens and inflammation while increasing IL-10. There was evidence of a possible trend towards enhanced kidney function in CKD patients treated with NSPT. TRIAL REGISTRATION: The study was registered in the Thai Clinical Trials Registry (TCTR20240516002; registered date 16 May 2024), Thailand.

BMC Oral Health
Prince of Songkla University (TH)
Good health and well-being
Openalex Percentile: Top 7%
Oral microbiology and periodontitis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.